Symbotic A Stock News

Demand for Symbotic's robotics automation systems remains strong. Symbotic just signed its first customer in healthcare, a company that's also about to launch an IPO.

Symbotic delivered blockbuster financial results and raised its guidance this week. In the wake of the better-than-expected results, several Wall Street analysts were playing catch-up, with an upgrade and several price target increases for the stock.

Warehouse automation company Symbotic‘s (SYM) stock has has more than doubled over the last year, greatly surpassing competitors GGG and GHM as of November 25, 2025. They spiked by close to 40% on Tuesday following a deal with Medline, a medical supplier.

Symbotic is deploying its AI-powered supply chain systems at an impressive clip. Surgical products giant Medline signed on as an important new customer.

Symbotic currently relies heavily on Walmart's business. But it just announced a new customer outside of the retail industry, and Wall Street is cheering.

Symbotic reported weak results in the fourth quarter, with revenue growth continuing to moderate and organic growth likely negative. System starts have rebounded over the past 18 months, though, which should lead to stronger growth in FY26. There are also signs that Symbotic could be starting to displace competitors.

Symbotic Inc  (NASDAQ:SYM) stock is up 36.1% to trade at $75.47 at last glance, after the robotics company reported fiscal fourth-quarter revenue of $618.5 million that surpassed analysts' estimates of $604 million.

Symbotic topped fiscal Q4 earnings expectations late Monday.